Lung Cancer | Specialty

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Immunotherapies, Novel Agents Push Envelope in SCLC

October 23rd 2019

With several agents in development, small cell lung cancer, which constitutes up to 15% of lung cancers, is the focus of increased clinical investigation that may make further treatment inroads.

Dr. Akerley on MET Biomarker in Lung Cancer

October 23rd 2019

Wallace L. Akerley, MD, discusses using MET as a biomarker in lung cancer.

Immunotherapy Success in Lung Cancer Sets Stage for Future Research

October 22nd 2019

Antoinette Wozniak, MD, FACP, FASCO, discusses the promise of immunotherapy in lung cancer and shared ongoing research efforts further exploring this approach.

Nivolumab/Ipilimumab Plus Chemo Improves OS in Frontline NSCLC

October 22nd 2019

The first-line combination of nivolumab (Opdivo) plus low-dose ipilimumab (Yervoy) given concomitantly with 2 cycles of chemotherapy showed superior overall survival compared with up to 4 cycles of chemotherapy alone followed by optional maintenance treatment in patients with advanced non–small cell lung cancer.

Dr. Yorio on T-DM1 in HER2-Mutant Lung Cancer Treatment

October 22nd 2019

Jeff Yorio, MD, discusses a small phase II study that is looking at using ado-trastuzumab emtansine to treat patients with HER2-mutant metastatic lung cancer.

ASCO Survey: E-Cigarettes Are Widely Misperceived as Harmless Among Young Adults

October 19th 2019

Findings from a national survey show that vaping is not only more common but also more favorably perceived among younger age groups than older adults.

Final Thoughts on Targeted Therapy and I/O Agents in NSCLC

October 18th 2019

Tumor Mutational Burden in Key Phase III Trials of NSCLC

October 18th 2019

Role of Tumor Mutational Burden in NSCLC

October 18th 2019

CASPIAN Trial: Durvalumab and Chemotherapy in ES-SCLC

October 18th 2019

I/O + Chemotherapy in Treatment-Naive ES-SCLC

October 18th 2019

Long-Term Outcomes With PD-1 Monotherapy in NSCLC

October 18th 2019

Role of I/O With Chemotherapy in Advanced Squamous NSCLC

October 18th 2019

CheckMate 817 Dual Immune-Checkpoint Inhibition in ECOG PS 2

October 18th 2019

CheckMate 227: Combining CTLA-4 and PD-L1 in NSCLC

October 18th 2019

Targeted Therapy for KRAS-Mutant NSCLC

October 18th 2019

LIBRETTO-001: RET-Fusion Positive Metastatic NSCLC

October 18th 2019

Strategies for Approaching Frontline Therapy in EGFR+ NSCLC

October 18th 2019

FLAURA Trial: Impact of OS Data in Advanced NSCLC

October 18th 2019

Notable RET Inhibitor Trials Underway

October 18th 2019